Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / France

Peptide legality · France · updated 2026-09-22

Are peptides legal in France?

Restricted

Peptides are legal in France only as authorized prescription medicines (e.g. prescription-only semaglutide or somatropin); unapproved 'research' peptides such as BPC-157 and TB-500 have no marketing authorization and cannot be lawfully sold or supplied for human use.

Legal status overview

In France, peptides are restricted: they are lawful only when they are medicines with a marketing authorization dispensed on prescription, while unapproved research peptides sold online are not authorized for human use. The national medicines regulator, the ANSM, classifies medicinal substances on the 'listes I et II des substances vénéneuses' under Article L.5132-6 of the Code de la santé publique, making them prescription-only. GLP-1 peptides like semaglutide are prescription medicines that ANSM has acted to secure, while consumer bodies have warned about peptides bought from online/social-media sellers.

Key points

  • In France, the ANSM classifies medicinal substances on the 'listes I et II des substances vénéneuses' under Article L.5132-6 of the Code de la santé publique, and substances so listed are prescription-only. [1]
  • GLP-1 peptide analogues such as semaglutide are prescription-only medicines in France, and the ANSM has issued measures to secure their use amid obesity/weight-loss demand. [2]
  • Semaglutide is available in France on prescription for weight management but is not reimbursed by public health insurance for that indication. [3]
  • French consumer authority UFC-Que Choisir has warned that peptides sold online, promoted via social media, are a risky trend, reflecting that such products are outside the authorized medicine channel. [4]
  • Research peptides like BPC-157 and TB-500 hold no French/EU marketing authorization (AMM), so they cannot be lawfully sold or dispensed for human use in France and circulate only as unapproved 'research chemicals'. [4]
  • For personal import/travel, French Customs rules allow individuals to carry medicines only within limits (broadly a personal-treatment quantity, typically up to three months, with a prescription), and unauthorized medicinal products may be blocked. [5]
  • Importing medicines into France outside the normal retail channel generally requires meeting ANSM import conditions/authorizations, and unauthorized peptides do not qualify for ordinary personal supply. [6]

Compound-by-compound status

BPC-157BPC-157 is not an authorized medicine in France, has no marketing authorization, and cannot be lawfully sold for human use, it circulates only as an unapproved research chemical that consumer authorities warn against buying online. [4]
Semaglutide (GLP-1, e.g. Ozempic®/Wegovy®)Semaglutide is legal in France strictly as a prescription-only medicine, available for weight management but not reimbursed for that use, with the ANSM having taken steps to secure its supply and prescribing. [2]
TB-500 (thymosin beta-4)TB-500 is not an authorized medicine in France and cannot be lawfully sold for human use; it is only found as an unapproved research peptide of the type consumer authorities warn is risky to buy online. [4]
HGH / somatropinHuman growth hormone (somatropin) is legal in France only as a prescription-only medicine; no specific source was verified in this research confirming its list classification, so this reflects the general prescription-medicine framework rather than a compound-specific citation. (no source found)

Frequently asked questions

Can I buy peptides in France without a prescription?

No, in France, medicinal peptides are prescription-only substances, and unapproved research peptides like BPC-157 have no marketing authorization and cannot be legally sold for human use, which is why consumer authorities warn against online sellers. [4]

Can I bring peptides into France for personal use?

Only within strict limits: French Customs permits individuals to carry medicines for personal treatment (broadly up to a three-month supply) with a prescription, and unauthorized peptides can be stopped at the border rather than treated as a permitted personal import. [5]

Can a doctor in France prescribe semaglutide for weight loss?

Yes, semaglutide is a prescription medicine in France and can be prescribed for weight management, though it is not reimbursed for that indication and the ANSM has set measures to secure its appropriate use. [2]

Is BPC-157 legal in France?

No, BPC-157 is not an authorized medicine in France, so it cannot be lawfully sold or supplied for human use and is available only as an unapproved research chemical that authorities caution against. [4]

Who regulates peptides in France?

In France, peptides are regulated by the ANSM (national medicines safety agency), which classifies medicinal substances on the 'listes I et II des substances vénéneuses' under the Code de la santé publique, with French Customs enforcing import limits. [1]

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in France, consult a licensed attorney or the national regulator.